Limited Competition for Continuation of the NIH Exploratory Trials in Parkinson's Disease (NET-PD): Clinical Sites (U10)
The summary for the Limited Competition for Continuation of the NIH Exploratory Trials in Parkinson's Disease (NET-PD): Clinical Sites (U10) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for Continuation of the NIH Exploratory Trials in Parkinson's Disease (NET-PD): Clinical Sites (U10): The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for a limited competition Funding Opportunity Announcement (FOA) utilizing a Cooperative Agreement (U10) to provide continuing support for Clinical Sites in the NIH Exploratory Trials in Parkinson's Disease network (NET-PD). The goal of this initiative is to support completion of NET-PD's current ongoing clinical trials.
Federal Grant Title: | Limited Competition for Continuation of the NIH Exploratory Trials in Parkinson's Disease (NET-PD): Clinical Sites (U10) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-NS-13-002 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.853 |
CFDA Descriptions: | Extramural Research Programs in the Neurosciences and Neurological Disorders |
Current Application Deadline: | Apr 17, 2012 |
Original Application Deadline: | Apr 17, 2012 |
Posted Date: | Jan 31, 2012 |
Creation Date: | Jan 31, 2012 |
Archive Date: | May 18, 2012 |
Total Program Funding: | $3,750,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Only currently active NET-PD Clinical Sites are eligible to apply. Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
- • NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
- • Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
- • Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- • Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dement...
- • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
- • NINDS Institutional Center Core Grants to Support Neuroscience Research
- • Career Development Award to Promote Diversity in Neuroscience Research
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)